
### [NCIT:C6516](http://purl.obolibrary.org/obo/NCIT_C6516)
**Label:** Malignant Skeletal Muscle Neoplasm

**Subclasses:** [NCIT:C5525](http://purl.obolibrary.org/obo/NCIT_C5525) (Prostate Embryonal Rhabdomyosarcoma), [NCIT:C6617](http://purl.obolibrary.org/obo/NCIT_C6617) (Mediastinal Rhabdomyosarcoma), [NCIT:C5847](http://purl.obolibrary.org/obo/NCIT_C5847) (Extrahepatic Bile Duct Embryonal Rhabdomyosarcoma), [NCIT:C5627](http://purl.obolibrary.org/obo/NCIT_C5627) (Rectal Rhabdomyosarcoma), [NCIT:C5522](http://purl.obolibrary.org/obo/NCIT_C5522) (Prostate Rhabdomyosarcoma), [NCIT:C4258](http://purl.obolibrary.org/obo/NCIT_C4258) (Pleomorphic Rhabdomyosarcoma), [NCIT:C4259](http://purl.obolibrary.org/obo/NCIT_C4259) (Rhabdomyosarcoma with Mixed Embryonal and Alveolar Features), [NCIT:C6378](http://purl.obolibrary.org/obo/NCIT_C6378) (Testicular Rhabdomyosarcoma), [NCIT:C5860](http://purl.obolibrary.org/obo/NCIT_C5860) (Extrahepatic Bile Duct Rhabdomyosarcoma), [NCIT:C5464](http://purl.obolibrary.org/obo/NCIT_C5464) (Central Nervous System Rhabdomyosarcoma), [NCIT:C8971](http://purl.obolibrary.org/obo/NCIT_C8971) (Embryonal Rhabdomyosarcoma), [NCIT:C49204](http://purl.obolibrary.org/obo/NCIT_C49204) (Anaplastic Embryonal Rhabdomyosarcoma), [NCIT:C123735](http://purl.obolibrary.org/obo/NCIT_C123735) (Fusion-Positive Rhabdomyosarcoma), [NCIT:C123736](http://purl.obolibrary.org/obo/NCIT_C123736) (Fusion-Negative Rhabdomyosarcoma), [NCIT:C5190](http://purl.obolibrary.org/obo/NCIT_C5190) (Breast Rhabdomyosarcoma), [NCIT:C9130](http://purl.obolibrary.org/obo/NCIT_C9130) (Adult Rhabdomyosarcoma), [NCIT:C123731](http://purl.obolibrary.org/obo/NCIT_C123731) (Fusion-Positive Alveolar Rhabdomyosarcoma), [NCIT:C123732](http://purl.obolibrary.org/obo/NCIT_C123732) (Fusion-Negative Alveolar Rhabdomyosarcoma), [NCIT:C121655](http://purl.obolibrary.org/obo/NCIT_C121655) (Sclerosing Rhabdomyosarcoma), [NCIT:C95623](http://purl.obolibrary.org/obo/NCIT_C95623) (Esophageal Rhabdomyosarcoma), [NCIT:C121654](http://purl.obolibrary.org/obo/NCIT_C121654) (Spindle Cell/Sclerosing Rhabdomyosarcoma), [NCIT:C128048](http://purl.obolibrary.org/obo/NCIT_C128048) (Cervical Rhabdomyosarcoma), [NCIT:C127058](http://purl.obolibrary.org/obo/NCIT_C127058) (Uterine Corpus Rhabdomyosarcoma), [NCIT:C6519](http://purl.obolibrary.org/obo/NCIT_C6519) (Spindle Cell Rhabdomyosarcoma), [NCIT:C3749](http://purl.obolibrary.org/obo/NCIT_C3749) (Alveolar Rhabdomyosarcoma), [NCIT:C5834](http://purl.obolibrary.org/obo/NCIT_C5834) (Liver Rhabdomyosarcoma), [NCIT:C128080](http://purl.obolibrary.org/obo/NCIT_C128080) (Vaginal Rhabdomyosarcoma), [NCIT:C8824](http://purl.obolibrary.org/obo/NCIT_C8824) (Recurrent Rhabdomyosarcoma), [NCIT:C5236](http://purl.obolibrary.org/obo/NCIT_C5236) (Ovarian Rhabdomyosarcoma), [NCIT:C5610](http://purl.obolibrary.org/obo/NCIT_C5610) (Anal Rhabdomyosarcoma), [NCIT:C3359](http://purl.obolibrary.org/obo/NCIT_C3359) (Rhabdomyosarcoma), [NCIT:C27369](http://purl.obolibrary.org/obo/NCIT_C27369) (Adult Pleomorphic Rhabdomyosarcoma), [NCIT:C45759](http://purl.obolibrary.org/obo/NCIT_C45759) (Cardiac Rhabdomyosarcoma), [NCIT:C5839](http://purl.obolibrary.org/obo/NCIT_C5839) (Gallbladder Rhabdomyosarcoma), [NCIT:C128273](http://purl.obolibrary.org/obo/NCIT_C128273) (Vulvar Alveolar Rhabdomyosarcoma), 

**Class expressions from DL-Learner:**

- Thing 52.77%
- [CL:0000188](http://purl.obolibrary.org/obo/CL_0000188) (cell of skeletal muscle) 39.52%
- [CL:0000188](http://purl.obolibrary.org/obo/CL_0000188) (cell of skeletal muscle) and (not ([NCIT:C39799](http://purl.obolibrary.org/obo/NCIT_C39799) (Loss of Chromosome 21))) 39.52%
- [CL:0000188](http://purl.obolibrary.org/obo/CL_0000188) (cell of skeletal muscle) and (not ([NCIT:C39798](http://purl.obolibrary.org/obo/NCIT_C39798) (Loss of Chromosome 2))) 39.52%
- [CL:0000188](http://purl.obolibrary.org/obo/CL_0000188) (cell of skeletal muscle) and (not ([NCIT:C39795](http://purl.obolibrary.org/obo/NCIT_C39795) (Loss of Chromosome 14q))) 39.52%
- [CL:0000188](http://purl.obolibrary.org/obo/CL_0000188) (cell of skeletal muscle) and (not ([NCIT:C39788](http://purl.obolibrary.org/obo/NCIT_C39788) (MET Gene Mutation))) 39.52%
- [CL:0000188](http://purl.obolibrary.org/obo/CL_0000188) (cell of skeletal muscle) and (not ([NCIT:C39787](http://purl.obolibrary.org/obo/NCIT_C39787) (Multiple Tumor Masses))) 39.52%
- [CL:0000188](http://purl.obolibrary.org/obo/CL_0000188) (cell of skeletal muscle) and (not ([NCIT:C39786](http://purl.obolibrary.org/obo/NCIT_C39786) (Bilateral Disease))) 39.52%
- [CL:0000188](http://purl.obolibrary.org/obo/CL_0000188) (cell of skeletal muscle) and (not ([NCIT:C39783](http://purl.obolibrary.org/obo/NCIT_C39783) (Retinal Hemangioblastoma))) 39.52%
- [CL:0000188](http://purl.obolibrary.org/obo/CL_0000188) (cell of skeletal muscle) and (not ([NCIT:C39752](http://purl.obolibrary.org/obo/NCIT_C39752) (Refractory Disease))) 39.52%
- [CL:0000188](http://purl.obolibrary.org/obo/CL_0000188) (cell of skeletal muscle) and (not ([NCIT:C39751](http://purl.obolibrary.org/obo/NCIT_C39751) (Glioblastoma, IDH-Mutant))) 39.52%
- [CL:0000188](http://purl.obolibrary.org/obo/CL_0000188) (cell of skeletal muscle) and (not ([NCIT:C39748](http://purl.obolibrary.org/obo/NCIT_C39748) (Lymphoblast-Like Neoplastic B-Lymphocyte))) 39.52%
- [CL:0000188](http://purl.obolibrary.org/obo/CL_0000188) (cell of skeletal muscle) and (not ([NCIT:C39747](http://purl.obolibrary.org/obo/NCIT_C39747) (Pleomorphic Variant Mantle Cell Lymphoma))) 39.52%
- [CL:0000188](http://purl.obolibrary.org/obo/CL_0000188) (cell of skeletal muscle) and (not ([NCIT:C39743](http://purl.obolibrary.org/obo/NCIT_C39743) (Fascicular Pattern))) 39.52%
- [CL:0000188](http://purl.obolibrary.org/obo/CL_0000188) (cell of skeletal muscle) and (not ([NCIT:C39741](http://purl.obolibrary.org/obo/NCIT_C39741) (Retroperitoneal Inflammatory Myofibroblastic Tumor))) 39.52%


